Gulf States refers to Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates. The second half of 2020 has seen an accelerated rate of normalisation of ties with Israel by Gulf states. The “Abraham Accords” were signed with the United Arab Emirates (UAE) in August, and Bahrain a month later normalising ties with Israel. 

Normalising relations includes but isn’t limited to resuming diplomatic ties, trade and investment agreements, technology and security agreements, etc. Oman and Saudi Arabia have established semi-official relations with Israel, with Saudi Arabia gauging the prospect of normalisation. Before August 2020, only two Arab countries had official ties with Israel – Egypt in 1979 and Jordan in 1994.

Progressive media are socially liberal and open to inclusion of migrants into society. Examples include: The Guardian, Huffpost, etc.

Under a global corporate minimum tax, all countries would agree to a minimum corporate tax rate (proposed to be 21% by the USA), but each country can decide upon its domestic tax rates for companies. Multi-national corporations paying less than the global minimum tax rates overseas would have to "top up" in their country of origin, to meet that tax rate. Countries not willing to join this global tax regime will be denied tax exemptions by other countries.

“Armchair Activism" refers to individuals sharing and posting content about injustices and social issues happening across the world on social media, without necessarily taking direct action to solve these injustices.

The narrative of the American Dream is the belief that anyone, regardless of where they were born, what class they were born into, what one's gender is, can attain their own version of success in American society, where upward mobility is possible for everyone. Meritocracy is a core tenet of the American Dream, emphasizing that success is achieved through hard work, rather than by chance.

The right to try refers to the legal granting to individuals with life-threatening conditions the opportunity to access ('try') experimental treatments - even ones that have yet to pass regulatory approval.